Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL003712

Drug Information
NameRG3616
SynonymsVismodegib
Trade NameErivedge
CompanyCuris; Roche
IndicationAdvanced basal cell carcinoma
[ICD9: 173   ICD10: C44]
Filed    
Operable basal cell carcinoma
[ICD9: 173   ICD10: C44]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5
-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)
InChIKeyBPQMGSKTAYIVFO-UHFFFAOYSA-N
Canonical SMILESCS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl    
CAS NumberCAS 879085-55-9
FormulaC19H14Cl2N2O3S
PubChem Compound IDCID 24776445.
ChEBI66903;
SuperDrug ATC IDL01XX43
TargetHedgehog Signaling Pathway



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543